Company Filing History:
Years Active: 2013-2025
Title: Innovator Bulusu Bhanu Teja from Hyderabad
Introduction
Bulusu Bhanu Teja, a prominent inventor based in Hyderabad, Telangana, India, has made significant contributions to the field of pharmaceuticals. With an impressive portfolio of 2 patents, Teja has been instrumental in developing innovative formulations aimed at improving the stability and efficacy of various medicinal compounds.
Latest Patents
Teja's latest patents include advancements in fulvestrant and daptomycin formulations. The first patent focuses on long-term storage stable fulvestrant-containing compositions that include fulvestrant, selected solvents such as dimethyl sulfoxide (DMSO), and a carefully curated oil mixture. These compositions ensure that total impurities remain below 5% after storage at controlled temperatures for at least 24 months.
The second patent details stable daptomycin-containing compositions, which maintain a pharmaceutical concentration of daptomycin of less than or equal to 25 mg/mL, alongside a specific buffer at a pH range of 6.0 to 7. This formulation remarkably shows resistance to degradation products associated with long-term storage, proving effective for at least 18 months.
Career Highlights
Bulusu Bhanu Teja is associated with Eagle Pharmaceuticals, Inc., where his innovative spirit thrives. The company's focus on developing high-quality pharmaceutical products complements Teja’s expertise in formulation science. His contributions have not only enhanced product stability but also improved patient safety and treatment outcomes.
Collaborations
Teja collaborates closely with Nagesh R Palepu, a coworker at Eagle Pharmaceuticals. Their partnership exemplifies teamwork in research and development, combining their expertise to drive forward innovative solutions in pharmaceuticals.
Conclusion
Bulusu Bhanu Teja's work stands as a testament to the dynamic nature of pharmaceutical innovations. With his patents focusing on stable formulations that enhance the usability and longevity of critical medications, he continues to pave the way for advancements that significantly benefit the healthcare industry. His journey in the domain of pharmaceutical inventions is one to watch, as he plays a vital role in shaping the future of medical treatments.